Jones Jeffrey A, Stroud Robert E, Kaplan Brooke S, Leone Allyson M, Bavaria Joseph E, Gorman Joseph H, Gorman Robert C, Ikonomidis John S
Division of Cardiothoracic Surgery, Department of Surgery, Medical University of South Carolina, Charleston, SC 29425, USA.
Circulation. 2007 Sep 11;116(11 Suppl):I144-9. doi: 10.1161/CIRCULATIONAHA.106.681361.
It is recognized that different events contribute to the initiation of ascending thoracic aortic aneurysms (ATAAs) in patients with bicuspid aortic valves (BAV) versus patients with tricuspid aortic valves (TAV), but the molecular signaling pathways driving aneurysm formation remain unclear. Protein kinase C (PKC) is a superfamily of kinases which differentially mediate signaling events that lead to altered gene expression and cellular function, and may regulate downstream mediators of vascular remodeling. The present study tested the hypothesis that ATAA development in patients with BAV versus TAV proceeds by independent signaling pathways involving differential PKC signaling.
ATAA samples were collected from BAV (n=57) and TAV (n=55) patients and assessed for 10 different PKC isoforms by immunoblotting. Results were expressed as a percent change in abundance (mean+/-SEM) from a nonaneurysmal control group (100%, n=21). Correlation analysis was performed, and relationships between PKC and matrix metalloproteinase abundance were reported. In the BAV group, classic and novel PKC isoforms (PKC-alpha, betaI, gamma, epsilon, theta) were increased, whereas PKC-eta and atypical PKC-zeta were decreased. In the TAV group, classic and novel isoforms were decreased and atypical PKC-zeta was elevated. Positive correlations between PKC and matrix metalloproteinase abundance were identified.
Differential PKC isoform abundance was observed in ATAA samples from patients with BAV versus TAV, suggesting independent molecular signaling pathways may be operative. Induction of independent transcriptional programs may result and may provide a mechanistic foundation for developing selective diagnostic/therapeutic strategies for patients with ATAAs secondary to BAV or TAV.
人们认识到,与三尖瓣主动脉瓣(TAV)患者相比,不同事件促成了二叶式主动脉瓣(BAV)患者升主动脉瘤(ATAAs)的发生,但驱动动脉瘤形成的分子信号通路仍不清楚。蛋白激酶C(PKC)是一个激酶超家族,其差异介导导致基因表达和细胞功能改变的信号事件,并可能调节血管重塑的下游介质。本研究检验了以下假设:BAV与TAV患者的ATAAs发展通过涉及不同PKC信号的独立信号通路进行。
从BAV(n = 57)和TAV(n = 55)患者中收集ATAAs样本,并通过免疫印迹法评估10种不同的PKC亚型。结果表示为与非动脉瘤对照组(100%,n = 21)相比丰度的百分比变化(平均值±标准误)。进行了相关性分析,并报告了PKC与基质金属蛋白酶丰度之间的关系。在BAV组中,经典和新型PKC亚型(PKC-α、βI、γ、ε、θ)增加,而PKC-η和非典型PKC-ζ减少。在TAV组中,经典和新型亚型减少,非典型PKC-ζ升高。确定了PKC与基质金属蛋白酶丰度之间的正相关。
在BAV与TAV患者的ATAAs样本中观察到不同的PKC亚型丰度,表明可能存在独立的分子信号通路。可能会导致独立转录程序的诱导,并可能为制定针对BAV或TAV继发的ATAAs患者的选择性诊断/治疗策略提供机制基础。